Ownership history in DAVIS SELECTED ADVISERS · 49 quarters on record
This page tracks every 13F SEC filing in which DAVIS SELECTED ADVISERS reported a position in Quest Diagnostics Inc Common (DGX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,589,883 | +228,271 | +16.8% | 1.24% | $275.9M | $172.74 |
| 2025 Q3 | ADDED | 1,361,612 | +7,192 | +0.5% | 1.35% | $259.5M | $188.87 |
| 2025 Q2 | REDUCED | 1,354,420 | -1,033,882 | -43.3% | 1.30% | $243.3M | $177.22 |
| 2025 Q1 | REDUCED | 2,388,302 | -8,958 | -0.4% | 2.33% | $404.1M | $166.11 |
| 2024 Q4 | REDUCED | 2,397,260 | -1,843 | -0.1% | 2.10% | $361.7M | $147.39 |
| 2024 Q3 | ADDED | 2,399,103 | +8,275 | +0.3% | 2.09% | $372.5M | $150.93 |
| 2024 Q2 | ADDED | 2,390,828 | +9,665 | +0.4% | 1.90% | $327.3M | $132.36 |
| 2024 Q1 | REDUCED | 2,381,163 | -285,401 | -10.7% | 1.78% | $317.0M | $127.98 |
| 2023 Q4 | ADDED | 2,666,564 | +998,866 | +59.9% | 2.08% | $367.7M | $131.87 |
| 2023 Q3 | ADDED | 1,667,698 | +153,810 | +10.2% | 1.27% | $203.2M | $115.87 |
As of 2025 Q4 — sorted by position size